This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feldman, T. Articles by Leon, M. B. Search for Related Content PubMed PubMed Citation Articles by Feldman, T. Articles by Leon, M. B. Related Collections Valvular heart disease Catheter-based coronary interventions: stents

(Circulation. 2007;116:2866-2877.)
© 2007 American Heart Association, Inc.

Advances in Interventional Cardiology

Prospects for Percutaneous Valve Therapies

Ted Feldman, MD; Martin B. Leon, MD

From Evanston Hospital (T.F.), Evanston, Ill, and Columbia University Medical Center (M.B.L.), New York, NY.

Address correspondence to Ted Feldman, MD, Evanston Hospital, Cardiology Division, Walgreen Bldg 3rd Floor, 2650 Ridge Ave, Evanston, IL 60201. E-mail tfeldman@enh.org

Key Words: aortic stenosis • mitral regurgitation • mitral valve • aortic valve

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Developmental efforts to achieve percutaneous catheter-based therapies for cardiac valve repair and replacement have advanced rapidly over the past several years. A variety of methods to treat mitral regurgitation (MR) and to replace aortic and pulmonic valves have already been successfully employed in patients. These innovative clinical transcatheter valve therapies were anticipated more than a decade ago by creative experimentalists who helped develop predicate techniques in animal models. For example, in 1992, a catheter-delivered ball-in-cage prosthetic aortic valve was implanted in a canine model by Pavcnik¹ and a stent-mounted bioprosthetic valve was placed by Andersen, who used a retrograde transarterial approach in a swine model.² Clearly, the catheter-based technologies used in clinical studies today in patients with aortic stenosis were derived from the fusion of known successful aortic valve replacement (AVR) surgical devices and adaptive interventional modalities, first studied in experimental animal models. Similarly, approaches for transcatheter treatment of MR have also borrowed heavily from preexisting and accepted surgical techniques, such as the edge-to-edge leaflet coaptation technique and reduction ring mitral annuloplasty.³ Importantly, recognition that the coronary sinus parallels the mitral annulus has spurred unique catheter-based transvenous approaches to treat MR by indirectly reducing mitral annular dimensions.⁴ Because many of the new percutaneous approaches to valve therapy have been developed by surgeons, a collaboration has emerged between thoughtful surgeons and interventionalists, combining skill sets and experiences to accelerate the developmental pathways of less-invasive transcatheter valve therapies.

	Unmet Clinical Needs

 
Growing recognition exists that percutaneous alternatives to surgical therapies are required in some patient . . . [Full Text of this Article]

This article has been cited by other articles:

				Y. Bai, G.-J. Zong, H.-B. Jiang, W.-P. Li, H. Wu, X.-X. Zhao, and Y.-W. Qin Percutaneous reimplantation of a pulmonary valved stent in sheep: A potential treatment for bioprosthetic valve degeneration J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 733 - 737. [Abstract] [Full Text] [PDF]

				S. Sack, P. Kahlert, L. Bilodeau, L. A. Pierard, P. Lancellotti, V. Legrand, J. Bartunek, M. Vanderheyden, R. Hoffmann, P. Schauerte, et al. Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With a Novel Coronary Sinus Implant Device Circ Cardiovasc Interv, August 1, 2009; 2(4): 277 - 284. [Abstract] [Full Text] [PDF]

				J. L. Quill, A. J. Hill, T. G. Laske, O. Alfieri, and P. A. Iaizzo Mitral leaflet anatomy revisited. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1077 - 1081. [Abstract] [Full Text] [PDF]

				J.-B. Masson and J. G. Webb Percutaneous Treatment of Mitral Regurgitation Circ Cardiovasc Interv, April 1, 2009; 2(2): 140 - 146. [Full Text] [PDF]

				H. C. Herrmann Transcatheter Aortic Valve Implantation: Past, Present, and Future Circ Cardiovasc Interv, December 1, 2008; 1(3): 159 - 160. [Full Text] [PDF]

				M. Mack Fool me once, shame on you; fool me twice, shame on me! A perspective on the emerging world of percutaneous heart valve therapy. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 816 - 819. [Full Text] [PDF]

				J. S. Gammie, L. S. Krowsoski, J. M. Brown, P. N. Odonkor, C. A. Young, M. J. Santos, J. S. Gottdiener, and B. P. Griffith Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population Circulation, September 30, 2008; 118(14): 1460 - 1466. [Abstract] [Full Text] [PDF]